Aberdeen divests Medivolve stake, stops being an insider, The Canadian Business Journal
TORONTO, September 27, 2022 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. or “Company”) (TSX: AAB) We are pleased to announce that we have sold 7,000,000 ordinary shares of Medivolve Co., Ltd.Medivolve”) (Neo: MEDV) on September 22, 2022, which reduced Aberdeen’s ownership from 1.7% of Medivolve’s outstanding common stock to less than 10% and Aberdeen is no longer a Medivolve insider.
We review our assets from time to time and may increase or decrease our positions depending on future conditions.
This news release is issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with the filing of the Early Warning Report dated September 29, 2022. The events leading up to this submission are the System for Electronic Document Analysis and Review (“seder“) under Medivolve’s publisher profile on www.sedar.com.
About Aberdeen International
Aberdeen International is a global resource investment firm and merchant bank focused on small capital companies in the rare metals and renewable energy sectors. Progressus Clean Technologies (formerly AES-100 Inc.) is an Aberdeen portfolio investment with exclusive rights and all intellectual property in advanced electrolyser systems for the production of hydrogen from lean syngas .
For more information, please visit our website www.aberdeen.green.
For more information, please contact:
Chris Younger
Chief executive officer
Aberdeen International Ltd.
[email protected]
(416) 861-1685
This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Forward-looking information includes, but is not limited to, statements regarding our investment portfolio. The renewable energy and natural resources sector and our future plans. Forward-looking information involves known and unknown risks, uncertainties and our actual results, level of activity, performance or achievements that may differ materially from those expressed or implied by such forward-looking information. Subject to other factors that may be contributing factors. Risks inherent in the mining industry and described in company public information available on his SEDAR company profile at www.sedar.com and on the company website at www.aberdeen.green. Although we have attempted to identify important factors that could cause our actual results to differ materially from those contained in the forward-looking information, we do not believe that results were anticipated, estimated or intended. There may be other factors that cause different. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. You should not place undue reliance on any forward-looking information. We do not undertake to update forward-looking information, except in accordance with applicable securities laws.
CBJ Newsmaker
Aberdeen divests Medivolve stake, stops being an insider, The Canadian Business Journal
Source link Aberdeen divests Medivolve stake, stops being an insider, The Canadian Business Journal